Participants are being sort for a research study looking into the mechanisms of PSP and to suggest potential novel targets to slow or stop the progression of the disease.
Invicro clinical research based at Hammersmith Hospital in London are undertaking a study for a research company called Sitilop.
The research will use Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI), to explore how the brain works and measure the accumulation of proteins which are potentially toxic to the brain nerve cells in PSP.
Each scan will last about 90 minutes. Researchers will perform a complete clinical and neuropsychological evaluation, plus the participants will be asked to provide a blood sample for routine tests.
The study consists of two sets of visits. For the first four participants these visits will last up to three months, while for the rest of them, these visits will last up to 15 months.
If you are living with PSP, are aged between 50 and 90 years old and are willing and able to travel to London, please contact Edoardo Natale for more information.
